Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation
- PMID: 3047021
- DOI: 10.1159/000215780
Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation
Abstract
Platelets are thought to be involved in the development of blood borne metastasis. Ultrastructural and experimental studies demonstrate that association between tumor cells and platelets with subsequent activation of the coagulation cascade takes place in malignancy. Several hypotheses have been proposed to explain the mechanisms by which tumor cells activate platelets including generation of thrombin, ADP release and involvement of arachidonate metabolism. Perfusion studies with human homologous systems showed that intact tumor cells and tumor cell microvesicles were able to induce platelet thrombogenicity under defined flow conditions. The presence of divalent cations and plasma factors was necessary for the cancer cells to exert their activating capacity. These results suggest a role for platelets in the development of secondary metastasis as well as in the thrombotic events of malignancy.
Similar articles
-
The role of platelets in cancer metastasis.Blood Coagul Fibrinolysis. 1990 Dec;1(6):707-11. Blood Coagul Fibrinolysis. 1990. PMID: 2133251 Review.
-
Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis.Haemostasis. 1988;18(1):37-46. doi: 10.1159/000215781. Haemostasis. 1988. PMID: 3047022 Review.
-
Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms.J Lab Clin Med. 1986 Dec;108(6):622-7. J Lab Clin Med. 1986. PMID: 3783031
-
Role of plasma, platelets, and endothelial cells in tumor metastasis.Cancer Metastasis Rev. 1984;3(2):99-114. doi: 10.1007/BF00047657. Cancer Metastasis Rev. 1984. PMID: 6386144 Review.
-
Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction.Science. 1976 Jun 4;192(4243):1011-2. doi: 10.1126/science.1273582. Science. 1976. PMID: 1273582
Cited by
-
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.J Clin Invest. 1993 Aug;92(2):804-13. doi: 10.1172/JCI116654. J Clin Invest. 1993. PMID: 7688763 Free PMC article.
-
Mechanism of Tumor-Platelet Communications in Cancer.Circ Res. 2023 May 26;132(11):1447-1461. doi: 10.1161/CIRCRESAHA.122.321861. Epub 2023 May 5. Circ Res. 2023. PMID: 37144446 Free PMC article.
-
Hemostatic changes in patients with brain tumors.J Neurooncol. 1994;22(2):87-100. doi: 10.1007/BF01052885. J Neurooncol. 1994. PMID: 7745471 Review.
-
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.Oncotarget. 2015 Dec 15;6(40):42733-48. doi: 10.18632/oncotarget.5811. Oncotarget. 2015. PMID: 26528756 Free PMC article.
-
MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.Mol Cancer. 2015 Mar 11;14:58. doi: 10.1186/s12943-015-0327-z. Mol Cancer. 2015. PMID: 25881295 Free PMC article.